Merck & Co snaps up 3 yr-old German biotech firm for up to $550 mln
September 06, 2017 at 09:57 AM EDT
FRANKFURT, Sept 6 (Reuters) - U.S. pharma group Merck & Co has acquired 3-1/2 year old German biotech start-up Rigontec for up to 464 million euros ($554 million), adding a new approach to its development of drugs that spur the immune system to attack tumours.
